Načítá se...

Matched cohort study on the efficacy of tocilizumab in patients with COVID-19

BACKGROUND: Tocilizumab has been proposed as a treatment for the new disease COVID-19, however, there is not enough scientific evidence to support this treatment. The objective of this study is to analyze whether the use of tocilizumab is associated with respiratory improvement and a shorter time to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:One Health
Hlavní autoři: Rodríguez-Molinero, Alejandro, Pérez-López, Carlos, Gálvez-Barrón, César, Miñarro, Antonio, Macho, Oscar, López, Gabriela F., Robles, Maria Teresa, Dapena, Maria Dolores, Martínez, Sergi, Rodríguez, Ezequiel, Pérez, Isabel Collado
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2021
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7784546/
https://ncbi.nlm.nih.gov/pubmed/33426262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.onehlt.2021.100214
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!